Johnson & Johnson sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.

  • DrPop@lemmy.one
    link
    fedilink
    English
    arrow-up
    8
    ·
    1 year ago

    But that ignores the nuance of the situation. If the application is to help people survive why shouldn’t the government tell them they can’t overcharge people?